Freeline Therapeutics Holdings plc (FRLN)

Etorro trading 970x250
Freeline Therapeutics Holdings plc (FRLN) Logo

About Freeline Therapeutics Holdings plc

Freeline Therapeutics Holdings plc operates as a clinical-stage systemic adeno-associated virus (AAV)-based gene therapy company. Its advanced product candidate is FLT180a, a gene therapy product candidate that is being evaluated in a Phase 1/2 dose-finding clinical trials in adult males for the treatment of patients with moderate or severe hemophilia B. The company’s products also include FLT190, which is in dose-escalating Phase 1/2 clinical trials for the treatment of Fabry disease; FLT201, a liver-directed gene therapy product candidate to treat type 1 Gaucher disease; and FLT210, a liver-directed gene therapy product candidate for the treatment of hemophilia A. In addition, it has research programs in various indications for systemic gene therapy. The company was founded in 2015 and is headquartered in Stevenage, the United Kingdom. Address: Stevenage Bioscience Catalyst, Stevenage, United Kingdom, SG1 2FX

Freeline Therapeutics Holdings plc News and around…

Latest news about Freeline Therapeutics Holdings plc (FRLN) common stock and company :

Freeline Announces Orphan Drug Designations for FLT201 for the Treatment of Gaucher Disease
09 Sep, 2021 FinancialContent

Clinical trial site initiation for Gaucher disease Type 1 on track by year end

Freeline to Participate in Upcoming Investor Conferences in September 2021
07 Sep, 2021 FinancialContent
10 Biggest Price Target Changes For Wednesday
18 Aug, 2021 FinancialContent

Barclays lifted Walmart Inc. (NYSE: WMT) price target from $165 to $170. Walmart shares rose 0.1% to $150.78 in pre-market ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
18 Aug, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We're halfway through the week but still going strong with a peek at the biggest pre-market stock movers for Wednesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

Benzinga's Top Ratings Upgrades, Downgrades For August 17, 2021
17 Aug, 2021 FinancialContent

Upgrades For Compass Minerals International Inc (NYSE:CMP), JP Morgan upgraded the previous rating of Underweight to ...

Is Freeline Therapeutics Holdings (NASDAQ:FRLN) In A Good Position To Deliver On Growth Plans?
17 Aug, 2021 Yahoo! Finance

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
17 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Freeline Appoints Michael J. Parini as Chief Executive Officer and Reports Second Quarter 2021 Financial Results
16 Aug, 2021 FinancialContent
78 Biggest Movers From Friday
16 Aug, 2021 FinancialContent

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported ...

12 Health Care Stocks Moving In Friday's Intraday Session
13 Aug, 2021 FinancialContent

Gainers Biolase (NASDAQ:BIOL) stock increased by 38.01% to $0.87 during Friday's regular session. Trading volume for ...

53 Stocks Moving In Friday's Mid-Day Session
13 Aug, 2021 FinancialContent

Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares climbed 30.9% to $0.8270 after the company reported better-than-expected Q2 sales. The ...

Freeline Provides Executive Leadership Team Update; Company to Provide Corporate Update and Second Quarter 2021 Financial Results on Monday, August 16
13 Aug, 2021 FinancialContent

Guidance across all programs remains unchanged for expected data and clinical development milestones in 2021

12 Health Care Stocks Moving In Thursday's After-Market Session
12 Aug, 2021 FinancialContent

Gainers Biolase (NASDAQ:BIOL) shares moved upwards by 24.95% to $0.79 during Thursday's after-market session. At the close, ...

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
12 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
11 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Stocks That Hit 52-Week Lows On Tuesday
10 Aug, 2021 FinancialContent

Before 10 a.m. ET on Tuesday, 60 companies set new 52-week lows. Key Facts: PACCAR (NASDAQ:PCAR) was the ...

The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
10 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

12 Health Care Stocks Moving In Friday's Pre-Market Session
30 Jul, 2021 FinancialContent

Gainers Erytech Pharma (NASDAQ:ERYP) shares moved upwards by 79.56% to $7.38 during Friday's pre-market session. The ...

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
28 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
27 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
23 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Stocks That Hit 52-Week Lows On Wednesday
21 Jul, 2021 FinancialContent

Wednesday's morning session saw 27 companies set new 52-week lows. Points of Interest: The company with ...

The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay
21 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

54 Biggest Movers From Yesterday
20 Jul, 2021 FinancialContent

Gainers Aehr Test Systems (NASDAQ: AEHR) shares climbed 87.9% to close at $6.39 on Monday after the company won a $10.8 million ...

30 Stocks Moving In Monday's Mid-Day Session
19 Jul, 2021 FinancialContent

Gainers Cytokinetics, Incorporated (NASDAQ: CYTK) jumped 56.4% to $30.07 after the company disclosed topline results from Cohorts ...

12 Health Care Stocks Moving In Monday's Pre-Market Session
19 Jul, 2021 FinancialContent

Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock moved upwards by 67.6% to $14.28 during Monday's pre-market session. ...

50 Biggest Movers From Friday
19 Jul, 2021 FinancialContent

Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares jumped 41.2% to settle at $7.10 on Friday. Blue Foundry Bancorp (NASDAQ: ...

The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
08 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Stocks That Hit 52-Week Lows On Thursday
01 Jul, 2021 FinancialContent

Thursday's morning session saw 13 companies set new 52-week lows. Things to Consider: Edgewise ...

Freeline Announces Executive Leadership Changes
30 Jun, 2021 FinancialContent

Freeline Therapeutics Holdings plc (FRLN) is a NASDAQ Common Stock listed in , ,

970x250